A comprehensive view of Tandem Diabetes Care Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Tandem Diabetes Care begins widespread US launch of Mobi, its smallest automated insulin delivery system for Type 1 diabetes, compatible with Dexcom's G6 CGM; rollout comes after success in the limited release phase

Abbott and Tandem Diabetes Care unveil wireless integration of Abbott's FreeStyle Libre 2 Plus continuous glucose monitor with Tandem's t:slim X2 insulin pump; US diabetes market forecast to grow to US$11.6B by 2025: GlobalData

Baird: Early data suggest GLP-1 weight-loss drugs like Ozempic can drive type-2 diabetes into remission; if fewer patients need an insulin pump to put insulin into the body, companies like Tandem Diabetes Care and Insulet could be hit hard

Tandem Diabetes Care plans late 2023 launch of slimmed-down X2 insulin pump system; system includes Dexcom G7 continuous glucose monitor sensor and Abbott FreeStyle Libre 2 and 3 integrations

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count